Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-17 Sale |
2023-05-19 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
4,122 | $21.38 | $88,108 | 927,880 (Indirect Direct) |
View |
| 2023-05-17 Sale |
2023-05-19 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
1,330 | $21.38 | $28,429 | 317,929 (Indirect Direct) |
View |
| 2023-05-17 Sale |
2023-05-19 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
245 | $21.38 | $5,237 | 6,116 (Direct) |
View |
| 2023-04-21 Sale |
2023-04-25 6:33 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
2,342 | $18.65 | $43,678 | 5,636 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-22 7:28 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
3,557 | $19.06 | $67,796 | 94,546 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-22 7:28 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
1,244 | $19.06 | $23,711 | 1,614 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-22 7:27 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
12,194 | $19.06 | $232,418 | 536,885 (Direct) |
View |
| 2022-10-06 Purchase |
2022-10-11 4:31 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See Remarks 10% Owner |
1,355,932 | $14.75 | $19,999,997 | 17,628,567 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | SOUTHWELL DAVID P Director |
25,850 | $0 | 25,850 (Direct) |
View |
| 2023-05-14 Exercise |
2023-05-16 8:04 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
7,979 | $0 | 987,858 (Direct) |
View |
| 2023-05-14 Exercise |
2023-05-16 8:01 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
725 | $0 | 11,439 (Direct) |
View |
| 2023-05-14 Exercise |
2023-05-16 7:57 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
3,989 | $0 | 347,241 (Direct) |
View |
| 2023-04-18 Exercise |
2023-04-20 6:34 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
6,364 | $0 | 20,648 (Direct) |
View |
| 2023-04-04 Option Award |
2023-04-12 7:00 pm |
N/A 2033-04-04 |
ROCKET PHARMACEUTICALS INC. | RCKT | White Mark Andrew Chief Medical Officer |
134,401 | $0 | 134,401 (Direct) |
View |
| 2022-05-19 Other |
2023-04-05 4:31 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See Remarks 10% Owner |
590,744 | $0 | 19,748,348 (Indirect) |
View |
| 2023-02-14 Option Award(A) |
2023-02-22 7:25 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
166,037 | $0 | 281,550 (Direct) |
View |
| 2023-02-14 Exercise(A) |
2023-02-22 7:25 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
8,574 | $0 | 281,550 (Direct) |
View |
| 2023-02-14 Option Award(A) |
2023-02-22 7:25 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
265,661 | $0 | 565,756 (Direct) |
View |
| 2023-02-14 Exercise(A) |
2023-02-22 7:25 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
15,720 | $0 | 565,756 (Direct) |
View |
| 2023-02-14 Option Award(A) |
2023-02-22 7:25 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
66,414 | $0 | 75,075 (Direct) |
View |
| 2023-02-14 Exercise(A) |
2023-02-22 7:25 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
2,858 | $0 | 75,075 (Direct) |
View |
| 2023-02-14 Option Award(A) |
2023-02-22 7:25 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
464,907 | $0 | 1,484,059 (Direct) |
View |
| 2023-02-14 Exercise(A) |
2023-02-22 7:25 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
31,440 | $0 | 1,484,059 (Direct) |
View |
| 2023-02-14 Option Award |
2023-02-16 4:45 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
116,226 | $0 | 116,226 (Direct) |
View |
| 2023-02-14 Option Award |
2023-02-16 4:45 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
66,414 | $0 | 66,414 (Direct) |
View |
| 2023-02-14 Option Award |
2023-02-16 4:45 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
166,037 | $0 | 166,037 (Direct) |
View |
| 2023-02-14 Option Award |
2023-02-16 4:45 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
265,661 | $0 | 265,661 (Direct) |
View |
| 2023-02-14 Option Award |
2023-02-16 4:45 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
464,907 | $0 | 464,907 (Direct) |
View |
| 2022-12-23 Other |
2022-12-23 4:42 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See Remarks 10% Owner |
1 | $0 | 1 (Indirect) |
View |
| 2022-12-22 Other |
2022-12-22 6:33 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See Remarks 10% Owner |
1 | $0 | 1 (Indirect) |
View |
| 2022-08-12 Option Award |
2022-08-16 5:33 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
22,896 | $0 | 22,896 (Direct) |
View |
| 2022-08-12 Option Award |
2022-08-16 5:31 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
52,489 | $0 | 52,489 (Direct) |
View |
| 2022-08-12 Option Award |
2022-08-16 5:27 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
14,310 | $0 | 14,310 (Direct) |
View |
| 2022-08-12 Option Award |
2022-08-16 5:24 pm |
N/A 2032-08-11 |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
49,081 | $0 | 49,081 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 9:07 pm |
N/A 2032-06-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Malik Fady Ibraham Director |
47,745 | $0 | 47,745 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 9:07 pm |
N/A 2032-06-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
47,745 | $0 | 53,621 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 9:07 pm |
N/A 2032-06-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
5,876 | $6.8 | 53,621 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 9:07 pm |
N/A 2032-06-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Yalamanchi Naveen Director |
47,745 | $0 | 47,745 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 9:07 pm |
N/A 2032-06-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director |
47,745 | $0 | 55,090 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 9:07 pm |
N/A 2032-06-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director |
7,345 | $6.8 | 55,090 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 9:07 pm |
N/A 2032-06-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | WONG RODERICK Director 10% Owner |
47,745 | $0 | 53,621 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 9:07 pm |
N/A 2032-06-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | WONG RODERICK Director 10% Owner |
5,876 | $6.8 | 53,621 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 9:07 pm |
N/A 2032-06-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | GRANADILLO PEDRO P Director |
47,745 | $0 | 58,028 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 9:07 pm |
N/A 2032-06-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | GRANADILLO PEDRO P Director |
10,283 | $6.8 | 58,028 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 9:07 pm |
N/A 2032-06-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | SOUTHWELL DAVID P Director |
47,745 | $0 | 47,745 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 9:07 pm |
N/A 2032-06-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | BOESS CARSTEN Director |
47,745 | $0 | 47,745 (Direct) |
View |
| 2022-04-18 Option Award |
2022-04-20 4:06 pm |
N/A 2032-04-17 |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
47,964 | $0 | 47,964 (Direct) |
View |